1) Beta blocker 
Bucindolol is a non-selective beta blocker with additional weak alpha-blocking properties and some intrinsic sympathomimetic activity. It was under review by the FDA in the United States for the treatment of heart failure in 2009 . ==Synthesis== Preparation of the amine for this agent starts by displacement of the dimethylamino group gramine by th...